A Review of the indications for initiating antiretroviral therapy in patients with CD4 counts over 350 in a London cohort

被引：0
|
作者：
Fernando, D. [1 ]
Kim, S-H [1 ]
Naous, N. [1 ]
Fidler, S. [1 ]
Mackie, N. [1 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, London, England
来源：
HIV MEDICINE | 2014年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：118 / 119
页数：2
相关论文
共 50 条
  • [41] Should we stop testing CD4 counts in HIV-infected individuals with viral suppression and CD4 ≥ 350?
    Whitlock, G. G.
    Ahmed, N.
    Edwards, S.
    Waters, L.
    HIV MEDICINE, 2013, 14 : 63 - 64
  • [42] Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
    Jean Joel R. Bigna
    Claudia S. Plottel
    Sinata Koulla-Shiro
    Infectious Diseases of Poverty, 5
  • [43] Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort
    Nabatanzi, Rose
    Bayigga, Lois
    Ssinabulya, Isaac
    Kiragga, Agnes
    Kambugu, Andrew
    Olobo, Joseph
    Joloba, Moses
    Kamya, Moses R.
    Mayanja-Kizza, Harriet
    Nakanjako, Damalie
    IMMUNOLOGY LETTERS, 2014, 162 (02) : 264 - 272
  • [44] Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
    Bigna, Jean Joel R.
    Plottel, Claudia S.
    Koulla-Shiro, Sinata
    INFECTIOUS DISEASES OF POVERTY, 2016, 5
  • [45] Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
    Bigna Jean Joel R
    Plottel Claudia S
    KoullaShiro Sinata
    贫困所致传染病（英文）, 2016, 5 (05) : 87 - 88-89-90-91-92
  • [46] Alcohol Consumption and CD4 T-Cell Count Response Among Persons Initiating Antiretroviral Therapy
    Kowalski, Stefan
    Colantuoni, Elizabeth
    Lau, Bryan
    Keruly, Jeanne
    McCaul, Mary E.
    Hutton, Heidi E.
    Moore, Richard D.
    Chander, Geetanjali
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (04) : 455 - 461
  • [47] Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK
    Kober, C.
    Johnson, M.
    Fisher, M.
    Hill, T.
    Anderson, J.
    Bansi, L.
    Gompels, M.
    Palfreeman, A.
    Dunn, D.
    Gazzard, B.
    Gilson, R.
    Post, F.
    Phillips, A. N.
    Walsh, J.
    Orkin, C.
    Delpech, V.
    Ainsworth, J.
    Leen, C.
    Sabin, C. A.
    HIV MEDICINE, 2012, 13 (01) : 73 - 78
  • [48] The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy
    Edelman, E. J.
    Gordon, K. S.
    Tate, J. P.
    Becker, W. C.
    Bryant, K.
    Crothers, K.
    Gaither, J. R.
    Gibert, C. L.
    Gordon, A. J.
    Marshall, B. D. L.
    Rodriguez-Barradas, M. C.
    Samet, J. H.
    Skanderson, M.
    Justice, A. C.
    Fiellin, D. A.
    HIV MEDICINE, 2016, 17 (10) : 728 - 739
  • [49] Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
    Serrano-Villar, Sergio
    Martinez-Sanz, Javier
    Ron, Raquel
    Talavera-Rodriguez, Alba
    Fernandez-Felix, Borja M.
    Herrera, Sabina
    Muriel, Alfonso
    Fanjul, Francisco
    Portilla, Joaquin
    Munoz, Josefa
    Amador, Concha
    Alberto de Zarraga, Miguel
    Vivancos, Maria J.
    Moreno, Santiago
    LANCET HIV, 2020, 7 (08): : E565 - E573
  • [50] Discontinuation of potent antiretroviral therapy:: predictive value of and impact on CD4 cell counts and HIV RNA levels
    Grant, LA
    Silverberg, MJ
    Palacio, H
    Minkoff, H
    Anastos, K
    Young, MA
    Nowicki, M
    Kovacs, A
    Cohen, M
    Muñoz, A
    AIDS, 2001, 15 (16) : 2101 - 2108
12345